Andrew A. Grimm

2.3k total citations · 2 hit papers
13 papers, 1.9k citations indexed

About

Andrew A. Grimm is a scholar working on Geriatrics and Gerontology, Nutrition and Dietetics and Oncology. According to data from OpenAlex, Andrew A. Grimm has authored 13 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Geriatrics and Gerontology, 4 papers in Nutrition and Dietetics and 3 papers in Oncology. Recurrent topics in Andrew A. Grimm's work include Clinical Nutrition and Gastroenterology (4 papers), Sirtuins and Resveratrol in Medicine (4 papers) and Glycogen Storage Diseases and Myoclonus (3 papers). Andrew A. Grimm is often cited by papers focused on Clinical Nutrition and Gastroenterology (4 papers), Sirtuins and Resveratrol in Medicine (4 papers) and Glycogen Storage Diseases and Myoclonus (3 papers). Andrew A. Grimm collaborates with scholars based in United States, Canada and Germany. Andrew A. Grimm's co-authors include Shin‐ichiro Imai, Javier R. Revollo, M. Alan Permutt, Eric L. Ford, Ernesto Bernal‐Mizrachi, Corentin Cras‐Méneur, Milad Rezvani, Holger Willenbring, David F. Mercer and Paul W. Wales and has published in prestigious journals such as Journal of Biological Chemistry, Hepatology and Cell Metabolism.

In The Last Decade

Andrew A. Grimm

12 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The NAD Biosynthesis Pathway Mediated by Nicotinamide Phosphoribosyltransferase Regulates Sir2 Activity in Mammalian Cells

2004 818 citations Javier R. Revollo, Andrew A. Grimm et al. Journal of Biological Chemistry profile →
Increased dosage of mammalian Sir2 in pancreatic β cells enhances glucose-stimulated insulin secretion in mice

2005 518 citations Andrew A. Grimm, Ernesto Bernal‐Mizrachi et al. Cell Metabolism profile →

Peers

Andrew A. Grimm

GG

PHYSI

EPIDE

MB

ONCOL

Myeong Jin Yoon United States

Karthikeyani Chellappa United States

Gina M. Warner United States

Dou Yeon Youn United States

Elisabeth Berber United States

Bhavapriya Vaitheesvaran United States

Acharawan Topark‐Ngarm United States

Maria Carla Motta Italy

Yibo Wu China

Ralph R. Alcendor United States

Myeong Jin Yoon United States

Andrew A. Grimm

787 ×0.8

GG

941 ×1.4

PHYSI

680 ×1.2

EPIDE

799 ×1.5

MB

320 ×0.9

ONCOL

Citations per year, relative to Andrew A. Grimm Andrew A. Grimm (= 1×) peers Myeong Jin Yoon

Countries citing papers authored by Andrew A. Grimm

Since Specialization

Citations

This map shows the geographic impact of Andrew A. Grimm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew A. Grimm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew A. Grimm more than expected).

Fields of papers citing papers by Andrew A. Grimm

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew A. Grimm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew A. Grimm. The network helps show where Andrew A. Grimm may publish in the future.

Co-authorship network of co-authors of Andrew A. Grimm

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew A. Grimm. A scholar is included among the top collaborators of Andrew A. Grimm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew A. Grimm. Andrew A. Grimm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

1.

Kruger, Eliza, et al.. (2025). Glycogen Storage Disease Type Ia: A Retrospective Claims Analysis of Complications, Resource Utilization, and Cost of Care. Journal of health economics and outcomes research. 12(1). 13–21. 1 indexed citations

2.

Kruger, Eliza, et al.. (2025). Glycogen Storage Disease Type Ia: A Retrospective Claims Analysis of Complications, Resource Utilization, and Cost of Care. Journal of health economics and outcomes research. 13–21. 1 indexed citations

3.

Zeng, Qing, Peter C.M. van Zijl, Yuguo Li, et al.. (2023). In vivo characterization of glycogen storage disease type III in a mouse model using glycoNOE MRI. Magnetic Resonance in Medicine. 91(3). 1115–1121. 8 indexed citations

4.

Nakamura, Shirô, Tsunekazu Mizushima, Akira Sugita, et al.. (2022). Efficacy, safety, and pharmacokinetics of teduglutide in adult Japanese patients with short bowel syndrome and intestinal failure: two phase III studies with an extension. Surgery Today. 53(3). 347–359. 7 indexed citations

5.

Hill, Susan, Beth A. Carter, Valeria Cohran, et al.. (2020). Safety Findings in Pediatric Patients During Long‐Term Treatment With Teduglutide for Short‐Bowel Syndrome–Associated Intestinal Failure: Pooled Analysis of 4 Clinical Studies. Journal of Parenteral and Enteral Nutrition. 45(7). 1456–1465. 18 indexed citations

6.

Kocoshis, Samuel A., Russell J. Merritt, Susan Hill, et al.. (2019). Safety and Efficacy of Teduglutide in Pediatric Patients With Intestinal Failure due to Short Bowel Syndrome: A 24‐Week, Phase III Study. Journal of Parenteral and Enteral Nutrition. 44(4). 621–631. 86 indexed citations

7.

Rezvani, Milad, Regina Español‐Suñer, Yann Malato, et al.. (2016). In Vivo Hepatic Reprogramming of Myofibroblasts with AAV Vectors as a Therapeutic Strategy for Liver Fibrosis. Cell stem cell. 18(6). 809–816. 105 indexed citations

8.

Rezvani, Milad, Andrew A. Grimm, & Holger Willenbring. (2016). Assessing the therapeutic potential of lab‐made hepatocytes. Hepatology. 64(1). 287–294. 36 indexed citations

9.

O’Keefe, Stephen J., Ulrich‐Frank Pape, Hak‐Myung Lee, Andrew A. Grimm, & Palle Bekker Jeppesen. (2016). Subanalysis of Teduglutide Efficacy and Safety Data from Patients with Crohnʼs Disease and Ulcerative Colitis in the STEPS Study. The American Journal of Gastroenterology. 111. S265–S265. 2 indexed citations

10.

Grimm, Andrew A., Cynthia S. Brace, Ting Wang, Gary D. Stormo, & Shin‐ichiro Imai. (2010). A nutrient‐sensitive interaction between Sirt1 and HNF‐1α regulates Crp expression. Aging Cell. 10(2). 305–317. 22 indexed citations

11.

Revollo, Javier R., Andrew A. Grimm, & Shin‐ichiro Imai. (2007). The regulation of nicotinamide adenine dinucleotide biosynthesis by Nampt/PBEF/visfatin in mammals. Current Opinion in Gastroenterology. 23(2). 164–170. 252 indexed citations

12.

Grimm, Andrew A., Ernesto Bernal‐Mizrachi, Eric L. Ford, et al.. (2005). Increased dosage of mammalian Sir2 in pancreatic β cells enhances glucose-stimulated insulin secretion in mice. Cell Metabolism. 2(2). 105–117. 518 indexed citations breakdown →

13.

Revollo, Javier R., Andrew A. Grimm, & Shin‐ichiro Imai. (2004). The NAD Biosynthesis Pathway Mediated by Nicotinamide Phosphoribosyltransferase Regulates Sir2 Activity in Mammalian Cells. Journal of Biological Chemistry. 279(49). 50754–50763. 818 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact